- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
来士普治疗老年抑郁症患者的疗效观察
精品论文 参考文献
来士普治疗老年抑郁症患者的疗效观察
黄玲1 向香义2 谢静3
1 广西壮族自治区人民医院 心理门诊 2 武警水电第一总队医院 内科 3柳州市柳铁中心医院 心理门诊
【摘要】目的:探讨来士普治疗老年抑郁症患者的疗效及其临床应用价值。方法:将138 例在本院治疗的老年抑郁症患者随机分为两组进行双盲对照实验, 每组69 例,对照组给予阿普唑仑治疗,观察组给予来士普治疗,疗程为6 周,以汉密尔顿抑郁量表( HAMD) 和治疗中出的症状量表(TESS) 评定治疗效果。结果: 观察组的有效率和总有效率为79.7%和94.2%,显著高于对照组的65.2%和85.5%( Plt; 0.05)。两组患者在治疗前HAMD、HAMA 评分无显著差异( Pgt;0.05 )。治疗 组患者在治疗两周后的HAMD、HAMA 评分出现显著下降( Plt; 0.05) ,而对照组在治疗4 周后出现了显著下降( Plt; 0.05)。对照组的不良反应发生率显著高于观察 组( Plt; 0.05)。结论:来士普治疗老年抑郁症患者的临床疗效较好,起效快,安全性高,能有效改善患者的抑郁状态,值得临床推广应用。
关键词:来士普;抑郁症;疗效
Observation on the clinical efficacy of lexapro in the treatment of elderly patients with depression [Abstract] Objective: To explore the clinical efficacy of lexapro in the treatment of senile depression and its clinical application value. Methods: 138 cases of the elderly patients with depression under double-blind trial in our hospital were randomly divided into two groups, 69 patients in each group, the control group was given alprazolam treatment, the observation group was given lexapro treatment, the treatment was lasting for 6 weeks, the clinical effect was evaluated with Hamilton Depression Scale (HAMD) symptom of the table and treatment (TESS). Results: The efficiency rate and total efficiency rate in observation group were 79.7% and 94.2%, significantly higher than those of the control group 65.2% and 85.5% (Plt; 0.05). No significant difference in HAMD, HAMA score of two groups before and after treatment (Pgt;0.05). The HAMD, HAMA score in treatment group patients decreased significantly in two weeks after the treatment (Plt; 0.05), while the HAMD, HAMA score in the control group had significantly decreased in 4 weeks after treatment (Plt; 0.05). Adverse reactions in the control group were significantly higher than those of the observation group (Plt; 0.05). Conclusions: Lexapro in the treatment of senile depression has a rapid clinical efficacy with high safety, which could effectively improve the depression in
文档评论(0)